The Patent Finder

Apogee Biologics, Inc.

Also on record
Records under this name other than patents Apogee Biologics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Apogee Biologics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,358,979Antibodies That Bind Interleukin 13 and Methods of Use
In force
 · High confidence
In forceHigh confidence
19/157,017Antibodies That Bind Interleukin 4 Receptor Alpha and Methods of Use
merged into Apogee Therapeutics Inc. - now held by Apogee Therapeutics, Inc.
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/234,011Antibodies That Bind Interleukin 13 and Methods of Use
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/425,386Antibodies That Bind OX40L and Methods of Use
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/425,771Antibodies That Bind Interleukin 4 Receptor Alpha and Methods of Use
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited